ATYPICAL TERATOID/RHABDOID TUMOR
Clinical trials for ATYPICAL TERATOID/RHABDOID TUMOR explained in plain language.
Never miss a new study
Get alerted when new ATYPICAL TERATOID/RHABDOID TUMOR trials appear
Sign up with your email to follow new studies for ATYPICAL TERATOID/RHABDOID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cells engineered to attack brain tumors in kids: new trial launches
Disease control Not yet recruitingThis early-phase study tests a personalized cell therapy called B7-H3 CAR T cells in 70 children and young adults whose brain tumors have come back or are growing despite standard treatment. The therapy uses the patient's own immune cells, modified to recognize and attack a prote…
Matched conditions: ATYPICAL TERATOID/RHABDOID TUMOR
Phase: PHASE1 • Sponsor: Robbie Majzner • Aim: Disease control
Last updated May 17, 2026 05:48 UTC
-
Engineered immune cells take on deadly childhood brain cancer
Disease control Not yet recruitingThis early-phase trial tests a new treatment for children with a rare and aggressive brain tumor called atypical teratoid rhabdoid tumor (ATRT) that has come back or not responded to standard therapy. The treatment uses the patient's own immune cells, modified in the lab to bette…
Matched conditions: ATYPICAL TERATOID/RHABDOID TUMOR
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 12, 2026 13:44 UTC